No Picture
News

Active Motif and EpiCypher Execute Cross-Licensing Agreement and End Ongoing Litigation Involving Targeted Transposition/CUT&Tag Technology for Epigenomics

CARLSBAD, Calif. and RESEARCH TRIANGLE PARK, N.C., Aug. 1, 2022 /PRNewswire/ — CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin-associated proteins through the precise insertion of DNA […]

No Picture
News

SEVEN RESEARCHERS HONORED FOR SCIENTIFIC ACHIEVEMENTS AND CONTRIBUTIONS TO THE DEMENTIA FIELD AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

SAN DIEGO, July 31, 2022 /PRNewswire/ — The Alzheimer’s Association® will present seven awards at the Alzheimer’s Association International Conference® (AAIC®) 2022, recognizing researchers for their varied expertise, noteworthy achievements and innovative contributions to the […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

C2N’s New Blood Test Combining p-tau217 Ratio with A?42/40 Ratio Points to Accuracy Levels Comparable to Existing Standards of Care for Amyloid Diagnosis in the Evaluation of Patients with Cognitive Impairment

SAN DIEGO–(BUSINESS WIRE)– #AAIC2022–Data released from C2N Diagnostics, presented today at the Alzheimer’s Association International Conference, demonstrated that a blood test combining the A?42/40 ratio, a component of C2N’s commercially available PrecivityADTM blood test, with […]

No Picture
News

ALZHEIMER’S ASSOCIATION GLOBAL WORKGROUP RELEASES RECOMMENDATIONS ABOUT USE OF ALZHEIMER’S “BLOOD TESTS”

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Top Tier Clinicians and Researchers Find the Tests Are: – Full of Revolutionary Potential – Valuable Now For Research and Treatment Trials – Not Ready Yet for the […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Evofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals

SAN DIEGO, July 29, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM), a women’s healthcare company, today commended the U.S. Department of Health and Human Services, alongside the Departments of Labor and of the Treasury […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Aethlon Medical Announces Publication of Peer-Reviewed Journal Article Describing Hemopurifier Resin Binding of Seven COVID-19 Variants

SAN DIEGO, July 28, 2022 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced the publication of […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

VyTrac Announces Pulmonary Intensive Care Unit Physician and Digital Health Champion Dr. Venktesh Ramnath to Join as Strategic Advisor

LOS ANGELES, July 28, 2022 /PRNewswire/ — VyTrac Health, Inc. (VyTrac), a leader in Remote Patient Monitoring (RPM) digital health technologies, announced today that Dr. Venktesh Ramnath, MD, an Intensive Care Unit Pulmonologist and a […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Innovate to Dominate

A new book from Tai Ming Cheung, “Innovate to Dominate: The Rise of the Chinese Techno-Security State,” examines the convergence of national security, innovation and economic development in China, detailing the … […]

No Picture
News

Innovate to Dominate

A new book from Tai Ming Cheung, “Innovate to Dominate: The Rise of the Chinese Techno-Security State,” examines the convergence of national security, innovation and economic development in China, detailing the … […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

First Patient Dosed in the ENLIGHTEN Biomarker-Guided Global Clinical Trial of DB104 (Liafensine) for Treatment-Resistant Depression

SAN DIEGO, July 28, 2022 /PRNewswire/ — Denovo Biopharma LLC (“Denovo”), a pioneer in applying precision medicine to the development of innovative therapies, today announced dosing of the first patient in its biomarker-guided global Phase […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Evofem Biosciences to Report Second Quarter 2022 Results and Provide Corporate Update on Thursday, August 4, 2022

— Conference Call Scheduled for 5:00 p.m. ET — SAN DIEGO, July 28, 2022 /PRNewswire/ — Evofem Biosciences, Inc., (Nasdaq: EVFM) will hold a webcast and conference call to discuss financial results and business highlights […]

No Picture
News

Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership

SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a JSR Life Sciences company, announced today that it has restructured its commercial leadership team by creating a new Chief Business Officer (CBO) role and with additional investment in commercial talent. […]

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Genentech to Present Scientific Progress Across Alzheimer’s Disease Pharmaceutical and Diagnostic Portfolio at 2022 AAIC Annual Meeting

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that data from 41 abstracts across its portfolio of Alzheimer’s disease pharmaceuticals and diagnostics will be presented […]

ADVERTISEMENT — Advertise With Biotech Networks